UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 766

Sortiert nach

HLA-corrected tumor mutation burden and homologous recombination deficiency for the prediction of response to PD-(L)1 blockade in advanced non-small-cell lung cancer patients

Annals of oncology, 2020-07, Vol.31 (7), p.902-911

2020

Link zum Volltext

Verfügbarkeit prüfen

Concomitant ALK translocation and EGFR mutation in lung cancer: a comparison of direct sequencing and sensitive assays and the impact on responsiveness to tyrosine kinase inhibitor

Annals of oncology, 2015-02, Vol.26 (2), p.348-354

2015

Link zum Volltext

Verfügbarkeit prüfen

Complex chromosomal rearrangements by single catastrophic pathogenesis in NUT midline carcinoma

Annals of oncology, 2017-04, Vol.28 (4), p.890-897

2017

Link zum Volltext

Verfügbarkeit prüfen

Final overall survival analysis for the phase II RECORD-3 study of first-line everolimus followed by sunitinib versus first-line sunitinib followed by everolimus in metastatic RCC

Annals of oncology, 2017-06, Vol.28 (6), p.1339-1345

2017

Link zum Volltext

Verfügbarkeit prüfen

Osimertinib plus platinum–pemetrexed in newly diagnosed epidermal growth factor receptor mutation-positive advanced/metastatic non-small-cell lung cancer: safety run-in results from the FLAURA2 study

ESMO open, 2021-10, Vol.6 (5), p.100271-100271, Article 100271

2021

Link zum Volltext

Verfügbarkeit prüfen

Phase II trial of everolimus for the treatment of nonclear-cell renal cell carcinoma

Annals of oncology, 2013-04, Vol.24 (4), p.1026-1031

2013

Link zum Volltext

Verfügbarkeit prüfen

Workload prediction using run-length encoding for runtime processor power management

Electronics letters, 2015-10, Vol.51 (22), p.1759-1761

2015

Link zum Volltext

Verfügbarkeit prüfen

Comparison of Three Commercial Model Based Segmentation Software and Atlas Based Segmentation Software in Contouring of Prostate Cancer and Brain Cancer

International journal of radiation oncology, biology, physics, 2015-11, Vol.93 (3), p.E605-E605

2015

Link zum Volltext

Verfügbarkeit prüfen

Acquired resistance mechanisms to INC280, a MET inhibitor in MET-amplified lung cancer cells

European journal of cancer (1990), 2016-12, Vol.69, p.S135-S136

2016

Link zum Volltext

Verfügbarkeit prüfen

EP-1082: Involved-site radiotherapy based on FDG-PET/CT after R-CHOP chemotherapy in diffuse large B cell lymphoma

Radiotherapy and oncology, 2014, Vol.111, p.S14-S14

2014

Link zum Volltext

Verfügbarkeit prüfen

153 Heterogeneity of Genetic Changes Associated with Acquired Crizotinib Resistance in Anaplastic Lymphoma Kinase-Rearranged Lung Cancer

European journal of cancer (1990), 2012-11, Vol.48, p.47-47

2012

Link zum Volltext

Verfügbarkeit prüfen

Efficacy of chemotherapy as a first-line treatment in ocular adnexal extranodal marginal zone B-cell lymphoma

Annals of oncology, 2008-02, Vol.19 (2), p.242-246

2008

Link zum Volltext

Verfügbarkeit prüfen

The Peroneus Quartus Muscle in a Locking Phenomenon of the Ankle: A Case Report

The Journal of foot and ankle surgery, 2017-01, Vol.56 (1), p.108-111

2017

Link zum Volltext

Verfügbarkeit prüfen

EP-1040 REDUCED-DOSE RADIOTHERAPY BY THE CHEMORESPONSIVENESS FOR THE PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA

Radiotherapy and oncology, 2012-05, Vol.103, p.S407-S407

2012

Link zum Volltext

Verfügbarkeit prüfen

EP-1052 RADICAL CHEMORADIOTHERAPY AS A TREATMENT OF CHOICE FOR THE ELDERLY WITH LOCALLY ADVANCED NSCLC

Radiotherapy and oncology, 2012-05, Vol.103, p.S411-S411

2012

Link zum Volltext

Verfügbarkeit prüfen

1491P PD-L1 TPS ≥50% predicts durable response after discontinuing immune checkpoint inhibitors in metastatic non-small cell lung cancer patients

Annals of oncology, 2023-10, Vol.34, p.S841-S842

2023

Link zum Volltext

Verfügbarkeit prüfen

Distribution and Failure Patterns of Primary Central Nervous System Lymphoma Related to Hippocampus

International journal of radiation oncology, biology, physics, 2023-10, Vol.117 (2), p.S160-S161

2023

Link zum Volltext

Verfügbarkeit prüfen

Vandetanib in pretreated patients with advanced non-small cell lung cancer-harboring RET rearrangement: a phase II clinical trial

Annals of oncology, 2017-02, Vol.28 (2), p.292-297

2017

Link zum Volltext

Verfügbarkeit prüfen

PO-1155 Distribution and failure patterns of primary central nervous system lymphoma related to hippocampus

Radiotherapy and oncology, 2023-05, Vol.182, p.S924-S925

2023

Link zum Volltext

Verfügbarkeit prüfen

7134 POSTER Updated Safety and Efficacy Results for Sunitinib From a Global, Expanded-Access Trial in Metastatic Renal Cell Carcinoma (mRCC)

European journal of cancer (1990), 2011, Vol.47, p.S515-S515

2011

Link zum Volltext

Verfügbarkeit prüfen

1194TiP AdvanTIG-205: Phase II trial of ociperlimab (OCI) + tislelizumab (TIS) + chemotherapy (chemo) in first line (1L) treatment of patients (pts) with locally advanced (LA), unresectable, or metastatic non-small cell lung cancer (mNSCLC)

Annals of oncology, 2022-09, Vol.33, p.S1094

2022

Link zum Volltext

Verfügbarkeit prüfen

Mechanisms of resistance to mobocertinib in EGFR exon 20 insertion-mutant non-small cell lung cancer (NSCLC)

European journal of cancer (1990), 2022-10, Vol.174, p.S110-S111

2022

Link zum Volltext

Verfügbarkeit prüfen

Molecular correlates of response to capmatinib in advanced non-small-cell lung cancer: clinical and biomarker results from a phase I trial

Annals of oncology, 2020-06, Vol.31 (6), p.789-797

2020

Link zum Volltext

Verfügbarkeit prüfen

Primary resistance to epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) in patients with non-small-cell lung cancer harboring TKI-sensitive EGFR mutations: an exploratory study

Annals of oncology, 2013-08, Vol.24 (8), p.2080-2087

2013

Link zum Volltext

Verfügbarkeit prüfen

1338P Cerebrospinal fluid pharmacokinetic study of lazertinib and pemetrexed in patients with EGFR-mutant non-small cell lung cancer with leptomeningeal metastases: KCSG21-01 LAZARUS trial

Annals of oncology, 2023-10, Vol.34, p.S771-S772

2023

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 766

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(652)
Mit Volltextzugriff
(720)

Publikationsform

Sprache

3 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(361)
Life Sciences & Biomedicine
(202)
Technology
(116)
Physics
(115)
Humans
(110)
Physical Sciences
(110)
Engineering
(70)
Female
(70)
Male
(63)
Animals
(52)
Biological And Medical Sciences
(52)
Engineering, Electrical & Electronic
(47)
Exact Sciences And Technology
(47)
Materials Science
(41)
Adult
(39)
Middle Aged
(36)
Chemistry
(34)
Oncology
(31)
Physics, Applied
(30)
Materials Science, Multidisciplinary
(28)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 7 Tagen
(3)
... seit 90 Tagen
(8)

Menü

Weitere Dienste

Einstellungen

HLA-corrected tumor mutation burden and homologous recombination deficiency for the prediction of response to PD-(L)1 blockade in advanced non-small-cell lung cancer patients

Concomitant ALK translocation and EGFR mutation in lung cancer: a comparison of direct sequencing and sensitive assays and the impact on responsiveness to tyrosine kinase inhibitor

Complex chromosomal rearrangements by single catastrophic pathogenesis in NUT midline carcinoma

Final overall survival analysis for the phase II RECORD-3 study of first-line everolimus followed by sunitinib versus first-line sunitinib followed by everolimus in metastatic RCC

Osimertinib plus platinum–pemetrexed in newly diagnosed epidermal growth factor receptor mutation-positive advanced/metastatic non-small-cell lung cancer: safety run-in results from the FLAURA2 study

Phase II trial of everolimus for the treatment of nonclear-cell renal cell carcinoma

Workload prediction using run-length encoding for runtime processor power management

Comparison of Three Commercial Model Based Segmentation Software and Atlas Based Segmentation Software in Contouring of Prostate Cancer and Brain Cancer

Acquired resistance mechanisms to INC280, a MET inhibitor in MET-amplified lung cancer cells

EP-1082: Involved-site radiotherapy based on FDG-PET/CT after R-CHOP chemotherapy in diffuse large B cell lymphoma

153 Heterogeneity of Genetic Changes Associated with Acquired Crizotinib Resistance in Anaplastic Lymphoma Kinase-Rearranged Lung Cancer

Efficacy of chemotherapy as a first-line treatment in ocular adnexal extranodal marginal zone B-cell lymphoma

The Peroneus Quartus Muscle in a Locking Phenomenon of the Ankle: A Case Report

EP-1040 REDUCED-DOSE RADIOTHERAPY BY THE CHEMORESPONSIVENESS FOR THE PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA

EP-1052 RADICAL CHEMORADIOTHERAPY AS A TREATMENT OF CHOICE FOR THE ELDERLY WITH LOCALLY ADVANCED NSCLC

1491P PD-L1 TPS ≥50% predicts durable response after discontinuing immune checkpoint inhibitors in metastatic non-small cell lung cancer patients

Distribution and Failure Patterns of Primary Central Nervous System Lymphoma Related to Hippocampus

Vandetanib in pretreated patients with advanced non-small cell lung cancer-harboring RET rearrangement: a phase II clinical trial

PO-1155 Distribution and failure patterns of primary central nervous system lymphoma related to hippocampus

7134 POSTER Updated Safety and Efficacy Results for Sunitinib From a Global, Expanded-Access Trial in Metastatic Renal Cell Carcinoma (mRCC)

1194TiP AdvanTIG-205: Phase II trial of ociperlimab (OCI) + tislelizumab (TIS) + chemotherapy (chemo) in first line (1L) treatment of patients (pts) with locally advanced (LA), unresectable, or metastatic non-small cell lung cancer (mNSCLC)

Mechanisms of resistance to mobocertinib in EGFR exon 20 insertion-mutant non-small cell lung cancer (NSCLC)

Molecular correlates of response to capmatinib in advanced non-small-cell lung cancer: clinical and biomarker results from a phase I trial

Primary resistance to epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) in patients with non-small-cell lung cancer harboring TKI-sensitive EGFR mutations: an exploratory study

1338P Cerebrospinal fluid pharmacokinetic study of lazertinib and pemetrexed in patients with EGFR-mutant non-small cell lung cancer with leptomeningeal metastases: KCSG21-01 LAZARUS trial

Suchergebnisse filtern